SEO fields: SEO title:COVID-19 indicated medical devices obtaining approval in Q3 2021: Exclusive analysis
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Q3 2021 saw a flat growth in COVID-19 medical device approvals

By Carmen 26 Oct 2021

The number of COVID-19 indicated medical devices gaining approval in Q3 2021 saw a flat growth when compared with Q2 2021, according to GlobalData’s medical devices marketed products database

Compared with Q3 2020, the number of COVID-19 indicated medical devices gaining approval in Q3 2021 saw a 58% drop globally.


Europe tops COVID-19 approved medical devices activity

Comparing COVID-19 medical device approvals activity in different regions of the globe, Europe held the top position for approved products (55%) in Q3 2021, followed by North America (24%), and Asia-Pacific (20%).

On a country level, the Germany had the most COVID-19 approved medical devices during the quarter, representing the largest share (50%) of the global market. In second place was United States with a share of 20%, followed by Australia with 8%.

COVID-19 marketed medical devices: Development activity in Q3 2021

GlobalData’s database indicated that CE-IVD marketed medical devices that addressed the COVID-19 pandemic accounted for 32% of medical devices in Q3 2021, compared with 32% in Q2 2021.

COVID-19 medical devices obtaining EUA approval declined to 42% in Q3 2021, compared with Q2 2021.

EUA have become more common during the COVID-19 pandemic, as an expeditious mechanism to bring therapeutic devices to market more quickly than normal device approvals.

Company-developed COVID-19 medical devices lead in Q3 2021

GlobalData’s databases indicated that company-developed medical devices accounted for a 97% share of approved COVID-19 devices globally during Q3 2021, while institute-developed marketed products held the remaining share.

The quarterly average for Q3 2021 saw 97% of approved COVID-19 indicated devices originating from private and public companies, and 3% from institutes.

Methodology
The Covid-19 medical devices approval data used in this article were extracted from Medical Marketed Products Database of GlobalData’s Medical Intelligence Center. Marketed Products database covers all commercialized medical devices which are intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. Marketed products are covered from regulatory bodies like US FDA, company websites, news releases, SEC filings etc. The information is collected by following systematic research techniques and proprietary methodology.

Carmen

Carmen is a robot, or rather an algorithmic journalist, who creates valuable automated content for our audiences. Carmen's focus is to deliver deep, fact-based articles and to free up our human journalists to interpret, analyse and explain developments.